A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor-deficient rabbit.

Treatment of low density lipoprotein (LDL) receptor-deficient rabbits (WHHL rabbits) with probucol (1% w/w in a chow diet) lowered their LDL-cholesterol levels by 36%, consonant with the reported effectiveness of the drug in patients deficient in the LDL receptor. Initial studies of LDL fractional c...

Full description

Bibliographic Details
Main Authors: M Naruszewicz, TE Carew, RC Pittman, JL Witztum, D Steinberg
Format: Article
Language:English
Published: Elsevier 1984-11-01
Series:Journal of Lipid Research
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520344643
id doaj-915ce580ba6e4728943cda7f68aec4cc
record_format Article
spelling doaj-915ce580ba6e4728943cda7f68aec4cc2021-04-25T04:16:06ZengElsevierJournal of Lipid Research0022-22751984-11-01251112061213A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor-deficient rabbit.M NaruszewiczTE CarewRC PittmanJL WitztumD SteinbergTreatment of low density lipoprotein (LDL) receptor-deficient rabbits (WHHL rabbits) with probucol (1% w/w in a chow diet) lowered their LDL-cholesterol levels by 36%, consonant with the reported effectiveness of the drug in patients deficient in the LDL receptor. Initial studies of LDL fractional catabolic rate (FCR) using 125I-labeled LDL prepared from the serum of untreated WHHL rabbits showed no difference between probucol-treated WHHL rabbits and untreated WHHL rabbits. When, however, 125I-labeled LDL was prepared from donor WHHL rabbits under treatment with probucol and injected back into them, the FCR was found to be increased by about 50% above that measured simultaneously using 131I-labeled LDL prepared from untreated WHHL donors. The labeled LDL from probucol-treated donors was also metabolized more rapidly than that from untreated donors when injected into untreated WHHL rabbits or into untreated wild-type New Zealand White rabbits. Finally, it was shown that rabbit skin fibroblasts in culture degraded labeled LDL prepared from probucol-treated WHHL rabbits more rapidly than that prepared from untreated WHHL donors. This was true both for normal rabbit fibroblasts and also for WHHL skin fibroblasts, although the absolute degradation rates in the latter were, of course, much lower for both forms of LDL. The data indicate that a major mechanism by which probucol lowers LDL levels relates not to changes in the cellular mechanisms for LDL uptake or to changes in LDL production but rather to intrinsic changes in the structure and metabolism of the plasma LDL of the probucol-treated animal.(ABSTRACT TRUNCATED AT 250 WORDS)http://www.sciencedirect.com/science/article/pii/S0022227520344643
collection DOAJ
language English
format Article
sources DOAJ
author M Naruszewicz
TE Carew
RC Pittman
JL Witztum
D Steinberg
spellingShingle M Naruszewicz
TE Carew
RC Pittman
JL Witztum
D Steinberg
A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor-deficient rabbit.
Journal of Lipid Research
author_facet M Naruszewicz
TE Carew
RC Pittman
JL Witztum
D Steinberg
author_sort M Naruszewicz
title A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor-deficient rabbit.
title_short A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor-deficient rabbit.
title_full A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor-deficient rabbit.
title_fullStr A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor-deficient rabbit.
title_full_unstemmed A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor-deficient rabbit.
title_sort novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the ldl receptor-deficient rabbit.
publisher Elsevier
series Journal of Lipid Research
issn 0022-2275
publishDate 1984-11-01
description Treatment of low density lipoprotein (LDL) receptor-deficient rabbits (WHHL rabbits) with probucol (1% w/w in a chow diet) lowered their LDL-cholesterol levels by 36%, consonant with the reported effectiveness of the drug in patients deficient in the LDL receptor. Initial studies of LDL fractional catabolic rate (FCR) using 125I-labeled LDL prepared from the serum of untreated WHHL rabbits showed no difference between probucol-treated WHHL rabbits and untreated WHHL rabbits. When, however, 125I-labeled LDL was prepared from donor WHHL rabbits under treatment with probucol and injected back into them, the FCR was found to be increased by about 50% above that measured simultaneously using 131I-labeled LDL prepared from untreated WHHL donors. The labeled LDL from probucol-treated donors was also metabolized more rapidly than that from untreated donors when injected into untreated WHHL rabbits or into untreated wild-type New Zealand White rabbits. Finally, it was shown that rabbit skin fibroblasts in culture degraded labeled LDL prepared from probucol-treated WHHL rabbits more rapidly than that prepared from untreated WHHL donors. This was true both for normal rabbit fibroblasts and also for WHHL skin fibroblasts, although the absolute degradation rates in the latter were, of course, much lower for both forms of LDL. The data indicate that a major mechanism by which probucol lowers LDL levels relates not to changes in the cellular mechanisms for LDL uptake or to changes in LDL production but rather to intrinsic changes in the structure and metabolism of the plasma LDL of the probucol-treated animal.(ABSTRACT TRUNCATED AT 250 WORDS)
url http://www.sciencedirect.com/science/article/pii/S0022227520344643
work_keys_str_mv AT mnaruszewicz anovelmechanismbywhichprobucollowerslowdensitylipoproteinlevelsdemonstratedintheldlreceptordeficientrabbit
AT tecarew anovelmechanismbywhichprobucollowerslowdensitylipoproteinlevelsdemonstratedintheldlreceptordeficientrabbit
AT rcpittman anovelmechanismbywhichprobucollowerslowdensitylipoproteinlevelsdemonstratedintheldlreceptordeficientrabbit
AT jlwitztum anovelmechanismbywhichprobucollowerslowdensitylipoproteinlevelsdemonstratedintheldlreceptordeficientrabbit
AT dsteinberg anovelmechanismbywhichprobucollowerslowdensitylipoproteinlevelsdemonstratedintheldlreceptordeficientrabbit
AT mnaruszewicz novelmechanismbywhichprobucollowerslowdensitylipoproteinlevelsdemonstratedintheldlreceptordeficientrabbit
AT tecarew novelmechanismbywhichprobucollowerslowdensitylipoproteinlevelsdemonstratedintheldlreceptordeficientrabbit
AT rcpittman novelmechanismbywhichprobucollowerslowdensitylipoproteinlevelsdemonstratedintheldlreceptordeficientrabbit
AT jlwitztum novelmechanismbywhichprobucollowerslowdensitylipoproteinlevelsdemonstratedintheldlreceptordeficientrabbit
AT dsteinberg novelmechanismbywhichprobucollowerslowdensitylipoproteinlevelsdemonstratedintheldlreceptordeficientrabbit
_version_ 1721510686142496768